Réseau de pathologie moléculaire pulmonaire du Québec

The RPMPQ is a network of Quebec clinical pathology laboratories performing thoracic oncology biomarker analysis, primarily for lung cancer.

Improving Molecular Diagnostics

for Quebec Lung Cancer Patients

The RPMPQ mission is to promote and improve molecular diagnostic testing for Quebec lung cancer patients and to facilitate access to screening for emerging biomarkers. The strengths of this network include a great team spirit and sharing of expert knowledge with the medical communities and with the patients.

Our network is founded on a strong team of pathologists and molecular biologists, who share a vision of advanced molecular screening of existing and emerging biomarkers by harmonizing testing algorithms, promoting translational research, and providing fair access to testing for Quebec patients, in particular through access of ongoing clinical studies.

Lung Oncology Biomarkers

A biomarker is a protein or molecular alteration found in a tumor that predicts sensitivity or resistance to one or more specific treatments.

Find out more

The Role of the Molecular Pathologist

A molecular pathologist and molecular biologists are responsible for analyzing the genetic profile of a patient's tumor.

Molecular Pathology in the Context of Lung Cancer

The development of lung cancer targeted therapies has given a privileged place for molecular pathology, which plays a crucial role in cancer diagnosis.